Seagen Inc.

09/19/2021 | Press release | Distributed by Public on 09/19/2021 09:51

Seagen and Genmab Present Interim Results From the innovaTV 205 Study for Tisotumab Vedotin Combination Therapy Treatment of Recurrent or Metastatic Cervical Cancer at ESMO[...]